UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

The immune system in the normal endometrium and implications for endometrial cancer development

Journal of reproductive immunology, 2015-06, Vol.109, p.7-16

2015

Volltextzugriff (PDF)

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines

Gene therapy, 2005-05, Vol.12 (9), p.772-782

2005

Volltextzugriff (PDF)

1090 Tumor-associated Antigen Validation in Uterine Tumors

European journal of cancer (1990), 2012-07, Vol.48, p.S262-S262

2012

Volltextzugriff (PDF)

Induction of antigen-specific CD8 cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA

Gene therapy, 2006-07, Vol.13 (13), p.1027-1036

2006

Volltextzugriff (PDF)

962MO A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells (myDC) in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma

Annals of oncology, 2021-09, Vol.32, p.S832-S833

2021

Volltextzugriff (PDF)

159P Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Annals of oncology, 2021-12, Vol.32, p.S1449-S1450

2021

Volltextzugriff (PDF)

342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial

Annals of oncology, 2021-09, Vol.32, p.S516-S517

2021

Volltextzugriff (PDF)

P06.05.A Repeated intracranial administration of ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii38-ii39

2022

Volltextzugriff (PDF)

65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma

Annals of oncology, 2020-12, Vol.31, p.S1443-S1443

2020

Volltextzugriff (PDF)

Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma

Journal of immunotherapy (1997), 2011-06, Vol.34 (5), p.448

2011

Volltextzugriff (PDF)

Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules

The Journal of immunology (1950), 2004-06, Vol.172 (11), p.6649-6657

2004

Volltextzugriff (PDF)

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma

Anticancer research, 2013-09, Vol.33 (9), p.3855-3859

2013

Volltextzugriff (PDF)

EP692 Fulvestrant in gynaecological cancers that are potentially hormone sensitive: the FUCHSia study

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A395-A395

2019

Volltextzugriff (PDF)

17P Exploiting the immune-modulatory effects of PI3K/mTOR inhibitors to enhance response to immune-checkpoint blockade in uterine leiomyosarcoma

ESMO open, 2023-03, Vol.8 (1), p.101038, Article 101038

2023

Volltextzugriff (PDF)

Generation of large numbers of dendritic cells in a closed system using Cell Factories

Journal of immunological methods, 2002-06, Vol.264 (1), p.135-151

2002

Volltextzugriff (PDF)

Side-by-Side Comparison of Lentivirally Transduced and mRNA-Electroporated Dendritic Cells: Implications for Cancer Immunotherapy Protocols

Molecular therapy, 2004-10, Vol.10 (4), p.768-779

2004

Volltextzugriff (PDF)

Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide

Cancer research (Chicago, Ill.), 2003-09, Vol.63 (17), p.5587-5594

2003

Volltextzugriff (PDF)

Dendritic cells differentiated in the presence of IFN-β and IL-3 are potent inducers of an antigen-specific CD8+ T cell response

Journal of leukocyte biology, 2005-10, Vol.78 (4), p.898-908

2005

Volltextzugriff (PDF)

Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells

Human gene therapy, 2004-06, Vol.15 (6), p.562-573

2004

Volltextzugriff (PDF)

Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells

Cancer gene therapy, 2003-09, Vol.10 (9), p.696-706

2003

Volltextzugriff (PDF)

Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4 super(+)CD25 super(+) regulatory T cells

Journal of leukocyte biology, 2007-07, Vol.82 (1), p.93-105

2007

Volltextzugriff (PDF)

FULVESTRANT IN GYNAECOLOGICAL CANCERS THAT ARE POTENTIALLY HORMONE SENSITIVE: THE FUCHSIA STUDY: EP692

International journal of gynecological cancer, 2019-11, Vol.29 ESGO Annual Meeting Abstracts, p.A395-A396

2019

Volltextzugriff (PDF)

Dendritic cells differentiated in the presence of IFN- beta and IL-3 are potent inducers of an antigen-specific CD8 super(+) T cell response

Journal of leukocyte biology, 2005-10, Vol.78 (4), p.898-908

2005

Volltextzugriff (PDF)

Induction of antigen-specific CDS super(+) cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA

Gene therapy, 2006-07, Vol.13 (13), p.1027-1036

2006

Volltextzugriff (PDF)

Generation of large numbers of dendritic cells in a closed system using Cell Factories registered

Journal of immunological methods, 2002-06, Vol.264 (1-2), p.135-151

2002

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(83)
Tagungsberichte
(6)

Sprache

Englisch
(89)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The immune system in the normal endometrium and implications for endometrial cancer development

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines

1090 Tumor-associated Antigen Validation in Uterine Tumors

Induction of antigen-specific CD8 cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA

962MO A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells (myDC) in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma

159P Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial

P06.05.A Repeated intracranial administration of ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial

65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma

Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma

Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma

EP692 Fulvestrant in gynaecological cancers that are potentially hormone sensitive: the FUCHSia study

17P Exploiting the immune-modulatory effects of PI3K/mTOR inhibitors to enhance response to immune-checkpoint blockade in uterine leiomyosarcoma

Generation of large numbers of dendritic cells in a closed system using Cell Factories

Side-by-Side Comparison of Lentivirally Transduced and mRNA-Electroporated Dendritic Cells: Implications for Cancer Immunotherapy Protocols

Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide

Dendritic cells differentiated in the presence of IFN-β and IL-3 are potent inducers of an antigen-specific CD8+ T cell response

Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells

Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells

Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4 super(+)CD25 super(+) regulatory T cells

FULVESTRANT IN GYNAECOLOGICAL CANCERS THAT ARE POTENTIALLY HORMONE SENSITIVE: THE FUCHSIA STUDY: EP692

Dendritic cells differentiated in the presence of IFN- beta and IL-3 are potent inducers of an antigen-specific CD8 super(+) T cell response

Induction of antigen-specific CDS super(+) cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA

Generation of large numbers of dendritic cells in a closed system using Cell Factories registered

Suchergebnisse filtern